Estimating Insulin Sensitivity in Pregnancies With Type 1 Diabetes
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Virginia
- Study ID
- NCT07351318
- Status
- Enrolling By Invitation
Conditions
- Pregnancy
- Type 1 Diabetes (T1D)
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The investigators want to learn how the body's response to insulin changes during pregnancy in people with Type 1 Diabetes. In this study, the investigators will look at information from people who used a Dexcom continuous glucose monitor (CGM) and a Tandem insulin pump while they were pregnant. Participants will fill out an online survey and agree to share their device data. The investigators will use this information to see how insulin sensitivity changes from three months before pregnancy to six months after the baby is born.
Key Dates
- Start date
- Feb 1, 2026
- Status verified
- Feb 2026
- Primary completion
- Jan 31, 2027
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 100 participants (estimated)
Primary Outcome Measure
Percent Time in Target Range [ Time Frame: Assessed every 2 weeks from 4 weeks pre-conception to 6 months post partum ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | - |
| UVA Health | Charlottesville | Virginia | 22903 | - |
Find similar trials in Chicago, IL
Related Studies
- Kidney Precision Medicine ProjectRecruiting · Icahn School of Medicine at Mount Sinai · Tucson, Arizona
- Beyond MARS: Magnetic Resonance Study: A Novel Assessment of Placental Perfusion During PregnancyRecruiting · Endeavor Health · Evanston, Illinois
- Oral Iron Supplementation on Alternate vs. Consecutive Days for Iron Deficiency Anemia in PregnancyPHASE4 · Recruiting · Southern Illinois University · Springfield, Illinois
- A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes MellitusPHASE1/PHASE2 · Recruiting · Otsuka Pharmaceutical Factory, Inc. · Chicago, Illinois